Christian Sebastian Michel

8PUBLICATIONS
53CO-AUTHORS
Medical mycologyLearning, motivation and emotionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|Mar 18, 2026
Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML.

Markus Meyerhöfer, Yawen Zhou, Aaron Gallego-Crespo

|Dec 22, 2025
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

Martin Grözinger, Muriel Schlanke, Jana Gröne

|Nov 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.

Tim Richardson, Elias Mai, Ekaterina Menis

|Apr 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.

Jan H Frenking, Xiang Zhou, Kai Rejeski

|Dec 09, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Elias K Mai, Uta Bertsch, Ema Pozek

Pageof 2

Frequent Collaborators

6 joint publications

Elias Mai

6 joint publications

Hartmut Goldschmidt

5 joint publications

Marc S Raab

4 joint publications

Carsten Müller-Tidow